Skip to main content

Table 5 Sero-Conversion Rates (SCR) for the two districts for each tested antibody

From: Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting

Kurunegala district

MSP1-Pf

AMA1-Pf

MSP1-Pv

AMA1-Pv

Any Pf antigen

Any Pv antigen

Model 1

 SCR

0.0079 (0.003-0.009)

0.0785 (0.025-0.104)

0.0133 (0.054-0.197)

0.1058 (0.048-0.177)

0.0582 (0.048-0.177)

0.1114 (0.048-0.177)

 SRR

0.0048 (10−13-1.307)

0.0608 (0.017-0.104)

0.0135 (0.003-0.124)

0.0890 (0.041-0.166)

0.0239 (0.004-5.43)

0.0576 (0.041-0.166)

Model 2

 SCR past

0.0026 (0.0006-0.03)

0.0045 (0.0025-0.0127)

0.1212 (10−4-0.33)

167.372 (2.66-1282.19)

0.0099 (0.002-1.282)

104.896 (2.66-128.21)

 SCR present

<10−4 (10−7-1.041)

0.0597 (0.0369-0.0679)

0.0123 (10−4-0.04)

0.0368 (0.030-0.543)

0.0612 (0.003-5.43)

0.0340 (0.003-0.542)

 SRR

0.0272 (0.006-0.06)

<10−4 (10−7-105)

0.0327 (0.0-1.0)

0.1369 (10−7-8.111)

<10−4 (10−8-105)

0.0930 (10−87-8.11)

 Change point

12

11

30

5

13

5

p-value (LRT)

0.061

0.115

0.015

0.049

0.087

0.058

Moneragala district

Model 1

 SCR

0.0665 (0.0131-0.188)

0.0548 (0.053-0.689)

0.0309 (10−3-1.36)

0.0536 (0.005-0.68)

0.0751 (0.04-0.177)

0.0653 (0.0091-0.13)

 SRR

<10−4 (10−7-5.59)

<10−4 (10−8-1.88)

<10−4 (10−41-2.97)

0.0003 (10−89-1.88)

<10−4 (10−5-0.166)

<10−4 (10−41-2.97)

Model 2

 SCR past

0.0192 (0.0050-0.0765)

0.1749 (0.022-0.35)

0.1312 (0.02-0.4)

0.1998 (0.022-0.35)

0.2572 (0.002-1.28)

0.2935 (0.022-0.49)

 SCR present

0.0011 (10−23-0.846)

0.0231 (0.003-0.129)

0.0022 (10−4-0.0026)

0.0256 (0.0035-0.129)

0.0268 (0.003-5.43)

0.0251 (10−4-0.269)

 SRR

<10−4 (10−23-1.085)

0.0026 (10−67-0.149)

0.0046 (10−7-3.48)

0.0038 (10−67-1.49)

<10−4 (10−87-8.11)

0.0002 (10−7-3.48)

 Change point

10

14

16

15

13

16

p-value (LRT)

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

  1. SCR was calculated assuming constant transmission intensity (Model 1) and a change of transmission intensity at a given change point (Model 2) with 95% Confidence Intervals within brackets. Sero-reversion rates (SRR) and log-likelihood associated with each model are also indicated. P-values refer to comparison between models one and two using the log-likelihood ratio test (LRT)